aluates Reports

$ 0.0

Automative

Global Small Molecule Chemical Drug CDMO Market Research Report 2024

Published Date: August 2024

Report Code: QYRE-Auto-36W16259

Global Small Molecule Chemical Drug CDMO Market Research Report 2023

BUY CHAPTERS

Global Small Molecule Chemical Drug CDMO Market Research Report 2024

Code: QYRE-Auto-36W16259

Report

August 2024

Pages:107

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Small Molecule Chemical Drug CDMO Market Size

The global Small Molecule Chemical Drug CDMO market was valued at US$ 47400 million in 2023 and is anticipated to reach US$ 103030 million by 2030, witnessing a CAGR of 12.0% during the forecast period 2024-2030.

Small Molecule Chemical Drug CDMO Market

The development and production of small molecule chemical drugs usually involves many complex steps, and the synthesis and production of small molecule chemical drugs require specialized equipment and technology. CDMO (Contract Development and Manufacturing Organization) is an organization that provides outsourcing services to pharmaceutical companies. It can provide a range of services from drug development to production.

North American market for Small Molecule Chemical Drug CDMO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Small Molecule Chemical Drug CDMO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Small Molecule Chemical Drug CDMO in Clinical Stage Projects is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Small Molecule Chemical Drug CDMO include Haixiang Pharmaceutical, Innovent Biologics, Betta Pharmaceuticals, Jiuzhou Pharmaceutical, Puluo Pharmaceutical, Menohua, Tianyu shares, Aoxiang Pharmaceutical and Hetero, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Small Molecule Chemical Drug CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule Chemical Drug CDMO.

Report Scope

The Small Molecule Chemical Drug CDMO market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Small Molecule Chemical Drug CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Small Molecule Chemical Drug CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Small Molecule Chemical Drug CDMO Market Report

Report Metric	Details
Report Name	Small Molecule Chemical Drug CDMO Market
Accounted market size in 2023	US$ 47400 million
Forecasted market size in 2030	US$ 103030 million
CAGR	12.0%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Human Medicine Veterinary Medicine
Segment by Application	Clinical Stage Projects Commercialization Stage Projects
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Haixiang Pharmaceutical, Innovent Biologics, Betta Pharmaceuticals, Jiuzhou Pharmaceutical, Puluo Pharmaceutical, Menohua, Tianyu shares, Aoxiang Pharmaceutical, Hetero, CellMark, R&D Systems, Porton Pharmaceuticals, Kai Laiying, Smart Life, Notai Biotech, Aurobindo Pharma, Lonza Group, Catalent Inc., Recipharm AB, Jubilant Pharmova Ltd, Patheon Inc. (Thermo Fisher Scientific Inc.), Boehringer Ingelheim Group, Pfizer CentreSource, Baxter International Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Molecule Chemical Drug CDMO companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Small Molecule Chemical Drug CDMO Market growing?

Ans: The Small Molecule Chemical Drug CDMO Market witnessing a CAGR of 12.0% during the forecast period 2024-2030.

What is the Small Molecule Chemical Drug CDMO Market size in 2030?

Ans: The Small Molecule Chemical Drug CDMO Market size in 2030 will be US$ 103030 million.

Who are the main players in the Small Molecule Chemical Drug CDMO Market report?

Ans: The main players in the Small Molecule Chemical Drug CDMO Market are Haixiang Pharmaceutical, Innovent Biologics, Betta Pharmaceuticals, Jiuzhou Pharmaceutical, Puluo Pharmaceutical, Menohua, Tianyu shares, Aoxiang Pharmaceutical, Hetero, CellMark, R&D Systems, Porton Pharmaceuticals, Kai Laiying, Smart Life, Notai Biotech, Aurobindo Pharma, Lonza Group, Catalent Inc., Recipharm AB, Jubilant Pharmova Ltd, Patheon Inc. (Thermo Fisher Scientific Inc.), Boehringer Ingelheim Group, Pfizer CentreSource, Baxter International Inc.

What are the Application segmentation covered in the Small Molecule Chemical Drug CDMO Market report?

Ans: The Applications covered in the Small Molecule Chemical Drug CDMO Market report are Clinical Stage Projects, Commercialization Stage Projects

What are the Type segmentation covered in the Small Molecule Chemical Drug CDMO Market report?

Ans: The Types covered in the Small Molecule Chemical Drug CDMO Market report are Human Medicine, Veterinary Medicine

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Small Molecule Chemical Drug CDMO Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Human Medicine

1.2.3 Veterinary Medicine

1.3 Market by Application

1.3.1 Global Small Molecule Chemical Drug CDMO Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Clinical Stage Projects

1.3.3 Commercialization Stage Projects

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Small Molecule Chemical Drug CDMO Market Perspective (2019-2030)

2.2 Small Molecule Chemical Drug CDMO Growth Trends by Region

2.2.1 Global Small Molecule Chemical Drug CDMO Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Small Molecule Chemical Drug CDMO Historic Market Size by Region (2019-2024)

2.2.3 Small Molecule Chemical Drug CDMO Forecasted Market Size by Region (2025-2030)

2.3 Small Molecule Chemical Drug CDMO Market Dynamics

2.3.1 Small Molecule Chemical Drug CDMO Industry Trends

2.3.2 Small Molecule Chemical Drug CDMO Market Drivers

2.3.3 Small Molecule Chemical Drug CDMO Market Challenges

2.3.4 Small Molecule Chemical Drug CDMO Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Small Molecule Chemical Drug CDMO Players by Revenue

3.1.1 Global Top Small Molecule Chemical Drug CDMO Players by Revenue (2019-2024)

3.1.2 Global Small Molecule Chemical Drug CDMO Revenue Market Share by Players (2019-2024)

3.2 Global Small Molecule Chemical Drug CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Small Molecule Chemical Drug CDMO Revenue

3.4 Global Small Molecule Chemical Drug CDMO Market Concentration Ratio

3.4.1 Global Small Molecule Chemical Drug CDMO Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Chemical Drug CDMO Revenue in 2023

3.5 Small Molecule Chemical Drug CDMO Key Players Head office and Area Served

3.6 Key Players Small Molecule Chemical Drug CDMO Product Solution and Service

3.7 Date of Enter into Small Molecule Chemical Drug CDMO Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Small Molecule Chemical Drug CDMO Breakdown Data by Type

4.1 Global Small Molecule Chemical Drug CDMO Historic Market Size by Type (2019-2024)

4.2 Global Small Molecule Chemical Drug CDMO Forecasted Market Size by Type (2025-2030)

5 Small Molecule Chemical Drug CDMO Breakdown Data by Application

5.1 Global Small Molecule Chemical Drug CDMO Historic Market Size by Application (2019-2024)

5.2 Global Small Molecule Chemical Drug CDMO Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Small Molecule Chemical Drug CDMO Market Size (2019-2030)

6.2 North America Small Molecule Chemical Drug CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Small Molecule Chemical Drug CDMO Market Size by Country (2019-2024)

6.4 North America Small Molecule Chemical Drug CDMO Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Small Molecule Chemical Drug CDMO Market Size (2019-2030)

7.2 Europe Small Molecule Chemical Drug CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Small Molecule Chemical Drug CDMO Market Size by Country (2019-2024)

7.4 Europe Small Molecule Chemical Drug CDMO Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Small Molecule Chemical Drug CDMO Market Size (2019-2030)

8.2 Asia-Pacific Small Molecule Chemical Drug CDMO Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Small Molecule Chemical Drug CDMO Market Size by Region (2019-2024)

8.4 Asia-Pacific Small Molecule Chemical Drug CDMO Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Small Molecule Chemical Drug CDMO Market Size (2019-2030)

9.2 Latin America Small Molecule Chemical Drug CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Small Molecule Chemical Drug CDMO Market Size by Country (2019-2024)

9.4 Latin America Small Molecule Chemical Drug CDMO Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Small Molecule Chemical Drug CDMO Market Size (2019-2030)

10.2 Middle East & Africa Small Molecule Chemical Drug CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Small Molecule Chemical Drug CDMO Market Size by Country (2019-2024)

10.4 Middle East & Africa Small Molecule Chemical Drug CDMO Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Haixiang Pharmaceutical

11.1.1 Haixiang Pharmaceutical Company Detail

11.1.2 Haixiang Pharmaceutical Business Overview

11.1.3 Haixiang Pharmaceutical Small Molecule Chemical Drug CDMO Introduction

11.1.4 Haixiang Pharmaceutical Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024)

11.1.5 Haixiang Pharmaceutical Recent Development

11.2 Innovent Biologics

11.2.1 Innovent Biologics Company Detail

11.2.2 Innovent Biologics Business Overview

11.2.3 Innovent Biologics Small Molecule Chemical Drug CDMO Introduction

11.2.4 Innovent Biologics Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024)

11.2.5 Innovent Biologics Recent Development

11.3 Betta Pharmaceuticals

11.3.1 Betta Pharmaceuticals Company Detail

11.3.2 Betta Pharmaceuticals Business Overview

11.3.3 Betta Pharmaceuticals Small Molecule Chemical Drug CDMO Introduction

11.3.4 Betta Pharmaceuticals Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024)

11.3.5 Betta Pharmaceuticals Recent Development

11.4 Jiuzhou Pharmaceutical

11.4.1 Jiuzhou Pharmaceutical Company Detail

11.4.2 Jiuzhou Pharmaceutical Business Overview

11.4.3 Jiuzhou Pharmaceutical Small Molecule Chemical Drug CDMO Introduction

11.4.4 Jiuzhou Pharmaceutical Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024)

11.4.5 Jiuzhou Pharmaceutical Recent Development

11.5 Puluo Pharmaceutical

11.5.1 Puluo Pharmaceutical Company Detail

11.5.2 Puluo Pharmaceutical Business Overview

11.5.3 Puluo Pharmaceutical Small Molecule Chemical Drug CDMO Introduction

11.5.4 Puluo Pharmaceutical Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024)

11.5.5 Puluo Pharmaceutical Recent Development

11.6 Menohua

11.6.1 Menohua Company Detail

11.6.2 Menohua Business Overview

11.6.3 Menohua Small Molecule Chemical Drug CDMO Introduction

11.6.4 Menohua Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024)

11.6.5 Menohua Recent Development

11.7 Tianyu shares

11.7.1 Tianyu shares Company Detail

11.7.2 Tianyu shares Business Overview

11.7.3 Tianyu shares Small Molecule Chemical Drug CDMO Introduction

11.7.4 Tianyu shares Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024)

11.7.5 Tianyu shares Recent Development

11.8 Aoxiang Pharmaceutical

11.8.1 Aoxiang Pharmaceutical Company Detail

11.8.2 Aoxiang Pharmaceutical Business Overview

11.8.3 Aoxiang Pharmaceutical Small Molecule Chemical Drug CDMO Introduction

11.8.4 Aoxiang Pharmaceutical Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024)

11.8.5 Aoxiang Pharmaceutical Recent Development

11.9 Hetero

11.9.1 Hetero Company Detail

11.9.2 Hetero Business Overview

11.9.3 Hetero Small Molecule Chemical Drug CDMO Introduction

11.9.4 Hetero Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024)

11.9.5 Hetero Recent Development

11.10 CellMark

11.10.1 CellMark Company Detail

11.10.2 CellMark Business Overview

11.10.3 CellMark Small Molecule Chemical Drug CDMO Introduction

11.10.4 CellMark Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024)

11.10.5 CellMark Recent Development

11.11 R&D Systems

11.11.1 R&D Systems Company Detail

11.11.2 R&D Systems Business Overview

11.11.3 R&D Systems Small Molecule Chemical Drug CDMO Introduction

11.11.4 R&D Systems Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024)

11.11.5 R&D Systems Recent Development

11.12 Porton Pharmaceuticals

11.12.1 Porton Pharmaceuticals Company Detail

11.12.2 Porton Pharmaceuticals Business Overview

11.12.3 Porton Pharmaceuticals Small Molecule Chemical Drug CDMO Introduction

11.12.4 Porton Pharmaceuticals Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024)

11.12.5 Porton Pharmaceuticals Recent Development

11.13 Kai Laiying

11.13.1 Kai Laiying Company Detail

11.13.2 Kai Laiying Business Overview

11.13.3 Kai Laiying Small Molecule Chemical Drug CDMO Introduction

11.13.4 Kai Laiying Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024)

11.13.5 Kai Laiying Recent Development

11.14 Smart Life

11.14.1 Smart Life Company Detail

11.14.2 Smart Life Business Overview

11.14.3 Smart Life Small Molecule Chemical Drug CDMO Introduction

11.14.4 Smart Life Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024)

11.14.5 Smart Life Recent Development

11.15 Notai Biotech

11.15.1 Notai Biotech Company Detail

11.15.2 Notai Biotech Business Overview

11.15.3 Notai Biotech Small Molecule Chemical Drug CDMO Introduction

11.15.4 Notai Biotech Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024)

11.15.5 Notai Biotech Recent Development

11.16 Aurobindo Pharma

11.16.1 Aurobindo Pharma Company Detail

11.16.2 Aurobindo Pharma Business Overview

11.16.3 Aurobindo Pharma Small Molecule Chemical Drug CDMO Introduction

11.16.4 Aurobindo Pharma Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024)

11.16.5 Aurobindo Pharma Recent Development

11.17 Lonza Group

11.17.1 Lonza Group Company Detail

11.17.2 Lonza Group Business Overview

11.17.3 Lonza Group Small Molecule Chemical Drug CDMO Introduction

11.17.4 Lonza Group Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024)

11.17.5 Lonza Group Recent Development

11.18 Catalent Inc.

11.18.1 Catalent Inc. Company Detail

11.18.2 Catalent Inc. Business Overview

11.18.3 Catalent Inc. Small Molecule Chemical Drug CDMO Introduction

11.18.4 Catalent Inc. Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024)

11.18.5 Catalent Inc. Recent Development

11.19 Recipharm AB

11.19.1 Recipharm AB Company Detail

11.19.2 Recipharm AB Business Overview

11.19.3 Recipharm AB Small Molecule Chemical Drug CDMO Introduction

11.19.4 Recipharm AB Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024)

11.19.5 Recipharm AB Recent Development

11.20 Jubilant Pharmova Ltd

11.20.1 Jubilant Pharmova Ltd Company Detail

11.20.2 Jubilant Pharmova Ltd Business Overview

11.20.3 Jubilant Pharmova Ltd Small Molecule Chemical Drug CDMO Introduction

11.20.4 Jubilant Pharmova Ltd Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024)

11.20.5 Jubilant Pharmova Ltd Recent Development

11.21 Patheon Inc. (Thermo Fisher Scientific Inc.)

11.21.1 Patheon Inc. (Thermo Fisher Scientific Inc.) Company Detail

11.21.2 Patheon Inc. (Thermo Fisher Scientific Inc.) Business Overview

11.21.3 Patheon Inc. (Thermo Fisher Scientific Inc.) Small Molecule Chemical Drug CDMO Introduction

11.21.4 Patheon Inc. (Thermo Fisher Scientific Inc.) Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024)

11.21.5 Patheon Inc. (Thermo Fisher Scientific Inc.) Recent Development

11.22 Boehringer Ingelheim Group

11.22.1 Boehringer Ingelheim Group Company Detail

11.22.2 Boehringer Ingelheim Group Business Overview

11.22.3 Boehringer Ingelheim Group Small Molecule Chemical Drug CDMO Introduction

11.22.4 Boehringer Ingelheim Group Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024)

11.22.5 Boehringer Ingelheim Group Recent Development

11.23 Pfizer CentreSource

11.23.1 Pfizer CentreSource Company Detail

11.23.2 Pfizer CentreSource Business Overview

11.23.3 Pfizer CentreSource Small Molecule Chemical Drug CDMO Introduction

11.23.4 Pfizer CentreSource Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024)

11.23.5 Pfizer CentreSource Recent Development

11.24 Baxter International Inc.

11.24.1 Baxter International Inc. Company Detail

11.24.2 Baxter International Inc. Business Overview

11.24.3 Baxter International Inc. Small Molecule Chemical Drug CDMO Introduction

11.24.4 Baxter International Inc. Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024)

11.24.5 Baxter International Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

Table 1. Global Small Molecule Chemical Drug CDMO Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Human Medicine

Table 3. Key Players of Veterinary Medicine

Table 4. Global Small Molecule Chemical Drug CDMO Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Small Molecule Chemical Drug CDMO Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Small Molecule Chemical Drug CDMO Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Small Molecule Chemical Drug CDMO Market Share by Region (2019-2024)

Table 8. Global Small Molecule Chemical Drug CDMO Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Small Molecule Chemical Drug CDMO Market Share by Region (2025-2030)

Table 10. Small Molecule Chemical Drug CDMO Market Trends

Table 11. Small Molecule Chemical Drug CDMO Market Drivers

Table 12. Small Molecule Chemical Drug CDMO Market Challenges

Table 13. Small Molecule Chemical Drug CDMO Market Restraints

Table 14. Global Small Molecule Chemical Drug CDMO Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Small Molecule Chemical Drug CDMO Market Share by Players (2019-2024)

Table 16. Global Top Small Molecule Chemical Drug CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Chemical Drug CDMO as of 2023)

Table 17. Ranking of Global Top Small Molecule Chemical Drug CDMO Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Small Molecule Chemical Drug CDMO Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Small Molecule Chemical Drug CDMO Product Solution and Service

Table 21. Date of Enter into Small Molecule Chemical Drug CDMO Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Small Molecule Chemical Drug CDMO Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Small Molecule Chemical Drug CDMO Revenue Market Share by Type (2019-2024)

Table 25. Global Small Molecule Chemical Drug CDMO Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Small Molecule Chemical Drug CDMO Revenue Market Share by Type (2025-2030)

Table 27. Global Small Molecule Chemical Drug CDMO Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Small Molecule Chemical Drug CDMO Revenue Market Share by Application (2019-2024)

Table 29. Global Small Molecule Chemical Drug CDMO Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Small Molecule Chemical Drug CDMO Revenue Market Share by Application (2025-2030)

Table 31. North America Small Molecule Chemical Drug CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Small Molecule Chemical Drug CDMO Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Small Molecule Chemical Drug CDMO Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Small Molecule Chemical Drug CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Small Molecule Chemical Drug CDMO Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Small Molecule Chemical Drug CDMO Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Small Molecule Chemical Drug CDMO Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Small Molecule Chemical Drug CDMO Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Small Molecule Chemical Drug CDMO Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Small Molecule Chemical Drug CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Small Molecule Chemical Drug CDMO Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Small Molecule Chemical Drug CDMO Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Small Molecule Chemical Drug CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Small Molecule Chemical Drug CDMO Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Small Molecule Chemical Drug CDMO Market Size by Country (2025-2030) & (US$ Million)

Table 46. Haixiang Pharmaceutical Company Detail

Table 47. Haixiang Pharmaceutical Business Overview

Table 48. Haixiang Pharmaceutical Small Molecule Chemical Drug CDMO Product

Table 49. Haixiang Pharmaceutical Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 50. Haixiang Pharmaceutical Recent Development

Table 51. Innovent Biologics Company Detail

Table 52. Innovent Biologics Business Overview

Table 53. Innovent Biologics Small Molecule Chemical Drug CDMO Product

Table 54. Innovent Biologics Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 55. Innovent Biologics Recent Development

Table 56. Betta Pharmaceuticals Company Detail

Table 57. Betta Pharmaceuticals Business Overview

Table 58. Betta Pharmaceuticals Small Molecule Chemical Drug CDMO Product

Table 59. Betta Pharmaceuticals Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 60. Betta Pharmaceuticals Recent Development

Table 61. Jiuzhou Pharmaceutical Company Detail

Table 62. Jiuzhou Pharmaceutical Business Overview

Table 63. Jiuzhou Pharmaceutical Small Molecule Chemical Drug CDMO Product

Table 64. Jiuzhou Pharmaceutical Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 65. Jiuzhou Pharmaceutical Recent Development

Table 66. Puluo Pharmaceutical Company Detail

Table 67. Puluo Pharmaceutical Business Overview

Table 68. Puluo Pharmaceutical Small Molecule Chemical Drug CDMO Product

Table 69. Puluo Pharmaceutical Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 70. Puluo Pharmaceutical Recent Development

Table 71. Menohua Company Detail

Table 72. Menohua Business Overview

Table 73. Menohua Small Molecule Chemical Drug CDMO Product

Table 74. Menohua Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 75. Menohua Recent Development

Table 76. Tianyu shares Company Detail

Table 77. Tianyu shares Business Overview

Table 78. Tianyu shares Small Molecule Chemical Drug CDMO Product

Table 79. Tianyu shares Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 80. Tianyu shares Recent Development

Table 81. Aoxiang Pharmaceutical Company Detail

Table 82. Aoxiang Pharmaceutical Business Overview

Table 83. Aoxiang Pharmaceutical Small Molecule Chemical Drug CDMO Product

Table 84. Aoxiang Pharmaceutical Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 85. Aoxiang Pharmaceutical Recent Development

Table 86. Hetero Company Detail

Table 87. Hetero Business Overview

Table 88. Hetero Small Molecule Chemical Drug CDMO Product

Table 89. Hetero Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 90. Hetero Recent Development

Table 91. CellMark Company Detail

Table 92. CellMark Business Overview

Table 93. CellMark Small Molecule Chemical Drug CDMO Product

Table 94. CellMark Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 95. CellMark Recent Development

Table 96. R&D Systems Company Detail

Table 97. R&D Systems Business Overview

Table 98. R&D Systems Small Molecule Chemical Drug CDMO Product

Table 99. R&D Systems Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 100. R&D Systems Recent Development

Table 101. Porton Pharmaceuticals Company Detail

Table 102. Porton Pharmaceuticals Business Overview

Table 103. Porton Pharmaceuticals Small Molecule Chemical Drug CDMO Product

Table 104. Porton Pharmaceuticals Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 105. Porton Pharmaceuticals Recent Development

Table 106. Kai Laiying Company Detail

Table 107. Kai Laiying Business Overview

Table 108. Kai Laiying Small Molecule Chemical Drug CDMO Product

Table 109. Kai Laiying Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 110. Kai Laiying Recent Development

Table 111. Smart Life Company Detail

Table 112. Smart Life Business Overview

Table 113. Smart Life Small Molecule Chemical Drug CDMO Product

Table 114. Smart Life Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 115. Smart Life Recent Development

Table 116. Notai Biotech Company Detail

Table 117. Notai Biotech Business Overview

Table 118. Notai Biotech Small Molecule Chemical Drug CDMO Product

Table 119. Notai Biotech Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 120. Notai Biotech Recent Development

Table 121. Aurobindo Pharma Company Detail

Table 122. Aurobindo Pharma Business Overview

Table 123. Aurobindo Pharma Small Molecule Chemical Drug CDMO Product

Table 124. Aurobindo Pharma Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 125. Aurobindo Pharma Recent Development

Table 126. Lonza Group Company Detail

Table 127. Lonza Group Business Overview

Table 128. Lonza Group Small Molecule Chemical Drug CDMO Product

Table 129. Lonza Group Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 130. Lonza Group Recent Development

Table 131. Catalent Inc. Company Detail

Table 132. Catalent Inc. Business Overview

Table 133. Catalent Inc. Small Molecule Chemical Drug CDMO Product

Table 134. Catalent Inc. Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 135. Catalent Inc. Recent Development

Table 136. Recipharm AB Company Detail

Table 137. Recipharm AB Business Overview

Table 138. Recipharm AB Small Molecule Chemical Drug CDMO Product

Table 139. Recipharm AB Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 140. Recipharm AB Recent Development

Table 141. Jubilant Pharmova Ltd Company Detail

Table 142. Jubilant Pharmova Ltd Business Overview

Table 143. Jubilant Pharmova Ltd Small Molecule Chemical Drug CDMO Product

Table 144. Jubilant Pharmova Ltd Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 145. Jubilant Pharmova Ltd Recent Development

Table 146. Patheon Inc. (Thermo Fisher Scientific Inc.) Company Detail

Table 147. Patheon Inc. (Thermo Fisher Scientific Inc.) Business Overview

Table 148. Patheon Inc. (Thermo Fisher Scientific Inc.) Small Molecule Chemical Drug CDMO Product

Table 149. Patheon Inc. (Thermo Fisher Scientific Inc.) Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 150. Patheon Inc. (Thermo Fisher Scientific Inc.) Recent Development

Table 151. Boehringer Ingelheim Group Company Detail

Table 152. Boehringer Ingelheim Group Business Overview

Table 153. Boehringer Ingelheim Group Small Molecule Chemical Drug CDMO Product

Table 154. Boehringer Ingelheim Group Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 155. Boehringer Ingelheim Group Recent Development

Table 156. Pfizer CentreSource Company Detail

Table 157. Pfizer CentreSource Business Overview

Table 158. Pfizer CentreSource Small Molecule Chemical Drug CDMO Product

Table 159. Pfizer CentreSource Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 160. Pfizer CentreSource Recent Development

Table 161. Baxter International Inc. Company Detail

Table 162. Baxter International Inc. Business Overview

Table 163. Baxter International Inc. Small Molecule Chemical Drug CDMO Product

Table 164. Baxter International Inc. Revenue in Small Molecule Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 165. Baxter International Inc. Recent Development

Table 166. Research Programs/Design for This Report

Table 167. Key Data Information from Secondary Sources

Table 168. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Small Molecule Chemical Drug CDMO Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Small Molecule Chemical Drug CDMO Market Share by Type: 2023 VS 2030

Figure 3. Human Medicine Features

Figure 4. Veterinary Medicine Features

Figure 5. Global Small Molecule Chemical Drug CDMO Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Small Molecule Chemical Drug CDMO Market Share by Application: 2023 VS 2030

Figure 7. Clinical Stage Projects Case Studies

Figure 8. Commercialization Stage Projects Case Studies

Figure 9. Small Molecule Chemical Drug CDMO Report Years Considered

Figure 10. Global Small Molecule Chemical Drug CDMO Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 11. Global Small Molecule Chemical Drug CDMO Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Small Molecule Chemical Drug CDMO Market Share by Region: 2023 VS 2030

Figure 13. Global Small Molecule Chemical Drug CDMO Market Share by Players in 2023

Figure 14. Global Top Small Molecule Chemical Drug CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Chemical Drug CDMO as of 2023)

Figure 15. The Top 10 and 5 Players Market Share by Small Molecule Chemical Drug CDMO Revenue in 2023

Figure 16. North America Small Molecule Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 17. North America Small Molecule Chemical Drug CDMO Market Share by Country (2019-2030)

Figure 18. United States Small Molecule Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. Canada Small Molecule Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Europe Small Molecule Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Small Molecule Chemical Drug CDMO Market Share by Country (2019-2030)

Figure 22. Germany Small Molecule Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. France Small Molecule Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. U.K. Small Molecule Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Italy Small Molecule Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Russia Small Molecule Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Nordic Countries Small Molecule Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Asia-Pacific Small Molecule Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Small Molecule Chemical Drug CDMO Market Share by Region (2019-2030)

Figure 30. China Small Molecule Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Japan Small Molecule Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. South Korea Small Molecule Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Southeast Asia Small Molecule Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. India Small Molecule Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Australia Small Molecule Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Latin America Small Molecule Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Small Molecule Chemical Drug CDMO Market Share by Country (2019-2030)

Figure 38. Mexico Small Molecule Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Brazil Small Molecule Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Middle East & Africa Small Molecule Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Small Molecule Chemical Drug CDMO Market Share by Country (2019-2030)

Figure 42. Turkey Small Molecule Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Saudi Arabia Small Molecule Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Haixiang Pharmaceutical Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2019-2024)

Figure 45. Innovent Biologics Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2019-2024)

Figure 46. Betta Pharmaceuticals Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2019-2024)

Figure 47. Jiuzhou Pharmaceutical Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2019-2024)

Figure 48. Puluo Pharmaceutical Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2019-2024)

Figure 49. Menohua Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2019-2024)

Figure 50. Tianyu shares Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2019-2024)

Figure 51. Aoxiang Pharmaceutical Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2019-2024)

Figure 52. Hetero Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2019-2024)

Figure 53. CellMark Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2019-2024)

Figure 54. R&D Systems Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2019-2024)

Figure 55. Porton Pharmaceuticals Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2019-2024)

Figure 56. Kai Laiying Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2019-2024)

Figure 57. Smart Life Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2019-2024)

Figure 58. Notai Biotech Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2019-2024)

Figure 59. Aurobindo Pharma Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2019-2024)

Figure 60. Lonza Group Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2019-2024)

Figure 61. Catalent Inc. Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2019-2024)

Figure 62. Recipharm AB Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2019-2024)

Figure 63. Jubilant Pharmova Ltd Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2019-2024)

Figure 64. Patheon Inc. (Thermo Fisher Scientific Inc.) Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2019-2024)

Figure 65. Boehringer Ingelheim Group Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2019-2024)

Figure 66. Pfizer CentreSource Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2019-2024)

Figure 67. Baxter International Inc. Revenue Growth Rate in Small Molecule Chemical Drug CDMO Business (2019-2024)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Stainless Steel Medication Trolley Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-18N15820

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Instant Molecular Testing Service Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-33G15638

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Universal Cell Therapy Drug Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-14U15769

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Preclinical Toxicology Testing Service Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-1P15930

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Small Molecule Chemical Drug CDMO Market Research Report 2024

Published Date: August 2024

Report Code: QYRE-Auto-36W16259

Global Small Molecule Chemical Drug CDMO Market Research Report 2024

FEATURED COMPANIES

Small Molecule Chemical Drug CDMO Market Size

Small Molecule Chemical Drug CDMO Market

Report Scope

Scope of Small Molecule Chemical Drug CDMO Market Report

Chapter Outline

FAQ for this report

How fast is Small Molecule Chemical Drug CDMO Market growing?

What is the Small Molecule Chemical Drug CDMO Market size in 2030?

Who are the main players in the Small Molecule Chemical Drug CDMO Market report?

What are the Application segmentation covered in the Small Molecule Chemical Drug CDMO Market report?

What are the Type segmentation covered in the Small Molecule Chemical Drug CDMO Market report?

FEATURED COMPANIES

RELATED REPORTS